QIAGEN Reports Strong Q3 2006 Results
14th Nov 2006, 02:17 GMT
18% Constant Currency and 11% Organic Revenue Growth in Consumables $0.14 Adjusted Earnings per Share: 17% Growth
QIAGEN Reports Strong Q3 2006 Results related news:
- eGene Reports a Profitable Quarter Result and Revenue Increases 273% in Q3 2006 Compared to Q3 2005 — Operations-Related News from StratCenter.com
- Stratagene Reports Q3 Results — Laboratory News from StratCenter.com
- Cardiogenesis Reports Q3 2006 Results — Surgery News from StratCenter.com
- Adherex Reports Q3 2006 Financial Results — Radiology News from StratCenter.com
- Chelsea Therapeutics Reports Q3 2006 Results — Operations-Related News from StratCenter.com
- Favrille Reports Q3 2006 Financial Results — StratWire - Business of Healthcare NewsFeed
- BioSante Pharmaceuticals Reports Q3 2006 Financial Results And Reviews Bio-E-Gel Marketing Agreement — Operations-Related News from StratCenter.com
- Viscount Systems Inc.: Viscount Reports Q3 2006 Results — Market Wire - Telecom
- Nymox Reports Q3 2006 Financial Results — Pharmaceuticals News from StratCenter.com
- Aksys Reports Q3 2006 Financial Results — Nephrology/ Dialysis News from StratCenter.com
Latest news from Financial News News from StratCenter.com:
- TRADE NEWS: Agilent Technologies Introduces High-Speed, High-Volume USB Multifunction Data Acquisition Modules, Chassis
- Bio-Rad Closes Buy of Ciphergen Unit
- The LGL Group Reports Q3 Earnings
- Analogic CEO to retire
- Analogic CEO Plans to Retire
- Meade Instruments Contracts with Leading Asian Outsource Manufacturing Firm
- JMAR Receives Nasdaq Delisting Notice
- Analogic Corp Announces Mgmt Changes
- Bio-Rad Purchases Life Science Research Business From Ciphergen Biosystems
- Agilent to buy Switzerland's Acqiris